Teladoc Health (TDOC) Receivables (2014 - 2026)

Teladoc Health's Receivables history runs 13 years deep, the most recent figure standing at $222.5 million for Q1 2026.

• In Q1 2026, Receivables fell 8.51% year-over-year to $222.5 million; the TTM figure through Mar 2026 stood at $222.5 million (down 8.51% YoY), while the FY2025 annual figure was $201.7 million, down 9.96% from the prior year.
• Receivables came in at $222.5 million for Q1 2026 at Teladoc Health, up from $201.7 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $243.2 million in Q1 2025 to a low of $201.7 million in Q4 2025.
• A 5-year average of $226.3 million and a median of $227.3 million in 2022 frame the typical range for Receivables.
• Across the five-year window, Receivables climbed 27.01% in 2022 and fell 9.96% in 2025, its largest moves.
• Teladoc Health's Receivables stood at $235.6 million in 2022, then retreated by 2.37% to $230.1 million in 2023, then retreated by 2.65% to $224.0 million in 2024, then dropped by 9.96% to $201.7 million in 2025, then climbed by 10.35% to $222.5 million in 2026.
• According to Business Quant data, Receivables over the past three periods registered $222.5 million, $201.7 million, and $219.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison